Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Assessment of hereditary angioedema treatment risks
Shana Kalaria
,
Timothy Craig
Department of Medicine
Department of Pediatrics
Division of Pulmonary, Allergy and Critical Care Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Assessment of hereditary angioedema treatment risks'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hereditary Angioedema
100%
Treatment Risk
100%
Adverse Events
57%
C1 Inhibitor
57%
Fresh Frozen Plasma
42%
Androgens
28%
Thrombosis
28%
Hepatocellular Carcinoma
28%
Indwelling Catheter
28%
Carcinoma
14%
Adverse Effects
14%
C1 Esterase Inhibitor
14%
Anaphylaxis
14%
Internet-based Survey
14%
Abnormal Events
14%
Danazol
14%
Thrombosis Risk
14%
Embolism
14%
Central Catheter
14%
Medicine and Dentistry
Hereditary Angioedema
100%
Adverse Event
71%
Isoniazid
57%
Thrombosis
42%
Fresh Frozen Plasma
42%
Androgen
28%
Hepatocellular Carcinoma
28%
Thromboembolism
28%
Complement Component C1s Inhibitor
28%
Metastatic Carcinoma
14%
Anaphylaxis
14%
Danazol
14%
Embolism
14%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Adverse Event
71%
Isoniazid
57%
Thrombosis
42%
Fresh Frozen Plasma
42%
Androgen
28%
Liver Cell Carcinoma
28%
Complement Component C1s Inhibitor
28%
Thromboembolism
28%
Anaphylaxis
14%
Danazol
14%
Embolism
14%
Nursing and Health Professions
Angioneurotic Edema
100%
Adverse Event
71%
Isoniazid
57%
Thrombosis
42%
Androgen
28%
Thromboembolism
28%
Liver Cell Carcinoma
28%
Indwelling Catheter
28%
Complement Component C1s Inhibitor
28%
Anaphylaxis
14%
Catheter
14%
Danazol
14%